Early Stage Treatment Questioned For Breast Cancer

Early Stage Treatment Questioned For Breast Cancer

New research has called a common treatment for early stage breast cancer into question. The treatment can often be disfiguring. According to a study published in the journal JAMA Oncology found that women with stage 0 breast cancer which is also known as ductal carcinoma in situ or DCIS who undergo treatment have the same likelihood of dying of breast cancer within 20 years as women in the general population. DCIS is often diagnosed after abnormal cells have been found in the breast's milk ducts. This is most often detected through a mammogram. It not makes up about one in five new breast cancer diagnoses according the American Cancer Society. The good thing is almost all women diagnosed at this stage can be cured. 

Read More

OVARIAN CANCER TREATMENT UNDERUSED: RESEARCH

OVARIAN CANCER TREATMENT UNDERUSED: RESEARCH

Less than half of women suffering from ovarian cancer who are qualified to get combined chemotherapy treatments only receive it. The study was published in the Journal of Clinical Oncology. It was a collaborative effort of six leading cancer institutes, including The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

Read More

Ovarian Cancer Screening: What Women Need to Know

Ovarian Cancer Screening: What Women Need to Know

Most women know the drill when it comes to screening for breast cancer and skin cancer, but many are unaware of the protocol and risk for ovarian cancer. Ovarian cancer is the fifth leading cause of cancer deaths in women.  This equates to about 250,000 women newly diagnosed annually, and 140,000 annual deaths from ovarian cancer.  Although ovarian cancer can occur at any age, women above the age of 60 are at higher risk.  Statistically, about half of diagnoses occur in women 63 years old and above. When diagnosis occurs in younger women, the cases are often more aggressive.

Read More

8 Medical Experts Evaluate the Female Viagra Sex Drug

8 Medical Experts Evaluate the Female Viagra Sex Drug

The FDA has approved the first female libido drug, from Sprout Pharmaceuticals called flibanserin. Many women who suffer from sexual dysfunction and lack of sexual desire are in support of the pill but critics worry that hard side effects may be a major concern. Researchers have been aware for many years that female sexual desire actually stems from the brain, which makes female desire or sexual disorders so difficult to treat. 

Read More